123ArticleOnline Logo
Welcome to 123ArticleOnline.com!
ALL >> General >> View Article

Rznomics: Circular Rna Platform Tech

Profile Picture
By Author: Ben Gross
Total Articles: 459
Comment this article
Facebook ShareTwitter ShareGoogle+ ShareTwitter Share

Rznomics, a biopharmaceutical company, has developed a groundbreaking 'self-circularized RNA structure' platform technology that efficiently generates circular RNA, overcoming the limitations of existing methods.

Circular RNA (circRNA) offers improved stability against nucleases and minimal unwanted immune responses, making it an attractive candidate for vaccines and therapeutics. Rznomics' technology utilizes a unique Tetrahymena trans-splicing ribozyme platform to convert linear RNA into circular RNA through an end-to-end self-targeting and splicing (STS) reaction. Unlike other methods, Rznomics' circularization does not leave unnecessary genetic information in the gene of interest (GOI). The efficiency of the self-circularization process is comparable to other methods, and various optimization strategies can be employed to increase its efficacy, even with long RNA molecules.

The significance of Rznomics' technology lies in its potential for commercialization, enabling more competitive pricing for circRNA vaccines or therapeutics while maintaining efficacy. In vitro transcription initiates the self-circularization ...
... reaction simultaneously, streamlining the purification process. The purified circRNA demonstrates sustained protein expression without unwanted immune responses, outperforming linear RNA with modified nucleotides.

The research was supported by the Ministry of Science & ICT and the National Research Foundation of Korea. Rznomics holds a patent for the 'Self-circularization RNA structure and Platform technology' in South Korea, with applications submitted in the U.S. and other major countries.

Rznomics is a biopharmaceutical company focused on RNA-based gene therapeutic bio-drugs for cancer and incurable diseases. Their core platform technology utilizes an RNA replacement enzyme, trans-splicing ribozyme, to selectively induce therapeutic gene activity in cells expressing target RNA. The company's lead candidate, RZ-001, is intended for treating Hepatocellular Carcinoma & Glioblastoma, with other treatments in the pipeline for Alzheimer's disease and hereditary retinal dystrophy.

More Information : https://www.techdogs.com/tech-news/pr-newswire/rznomics-presents-its-own-circular-rna-platform-technology

Total Views: 535Word Count: 272See All articles From Author

Add Comment

General Articles

1. Amazon.de Vs Kaufland Vs Allegro Price Monitoring Eu
Author: Actowiz Metrics

2. Cissp Certification: Complete Guide To Requirements, Exam, Cost & Online Training
Author: Passyourcert

3. Reliable Myfitnesspal Api Alternatives For Nutrition Data
Author: webfusion

4. Rcdd Career Opportunities: Build Your Future In Telecommunications
Author: Cert Grow

5. Common Air Conditioning Problems And How To Keep Your System Running Efficiently
Author: airconsmau

6. How Customer Support Outsourcing Improves The Online Shopping Experience
Author: MWA

7. Agentic Ai Course In Hyderabad | Agentic Ai Online
Author: Hari

8. Software Company In Bhubaneswar: How To Choose The Right Technology Partner In 2026
Author: NTSPL Hosting

9. Oscp+ Practice Labs: Build Hands-on Penetration Testing Skills
Author: Oscptraining Seo

10. Indian Retailer Product Data Scraping
Author: IWEB

11. Coinmarketcap Clone Software: Development Process, Architecture, And Business Opportunities
Author: Ryan

12. Carbide Inserts: Types, Applications And How To Choose The Right Insert For Cnc Machining
Author: Metaldur

13. Keratin Treatment In Anna Nagar – A Guide To Professional Hair Smoothing
Author: raj

14. Pourquoi Faire Appel à Une Agence Locale Pour Organiser Un Voyage En Odisha ?
Author: UTTAM

15. Eufy Products Analytics On Amazon Usa For Market Insights
Author: Actowiz Metrics

Login To Account
Login Email:
Password:
Forgot Password?
New User?
Sign Up Newsletter
Email Address: